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59 Objective: Conduct a systematic review and meta-analysis examining the association between 
60 hypertensive disorders of pregnancy (HDP) and risk of asthma, eczema, food allergies and allergic 









This article is protected by copyright. All rights reserved
62 Design: A systematic review and random effects meta-analyses were used to synthesise the 
63 published literature. PRISMA guidelines were followed throughout. Two independent reviewers 
64 carried out data extraction and quality assessment of included studies. Grading of 
65 Recommendations Assessment, Development and Evaluation (GRADE) was used to assess 
66 certainty of findings.
67 Data Sources: A systematic search of PubMed, Embase, Web of Science and CINAHL was 
68 performed from inception of databases-April 21, 2020, supplemented by hand-searching reference 
69 lists of included articles.
70 Eligibility Criteria: Two reviewers independently reviewed titles, abstracts, and full-text articles. 
71 English-language, cohort, case-control and cross-sectional published studies examining the 
72 association between HDP (primary exposure: preeclampsia; secondary exposures: all other HDP) 
73 and asthma, eczema, food allergies and allergic rhinitis were included. 
74 Results: Of the 2,833 studies retrieved, 14 studies met inclusion criteria. Of these, 11 studies 
75 reported evidence of association between HDP and atopic disorders. Thirteen studies reported 
76 estimates for asthma. Seven of these included adjusted estimates (including 3,645,773 
77 participants) for a preeclampsia-asthma relationship resulting in a pooled odds ratio (OR) of 1.14 
78 (95% CI: 1.04, 1.26) (I2=62%). However, this OR was reduced to 1.08 (95% CI: (0.78, 1.48) when 
79 the large registry based cohort studies were excluded, and only studies using  parent-reported 
80 measures to determine a diagnosis of asthma were included. Four studies included adjusted 
81 estimates (including 254,998 participants) for other HDP and asthma (pooled OR: 1.02, 95% CI: 
82 0.96, 1.09) (I2=0%). Two studies provided adjusted estimates (including 1,699,663 participants) 
83 for a preeclampsia-eczema relationship (pooled OR: 1.06, 95% CI: 0.98, 1.14) (I2=0%). One study 
84 including preeclampsia-food allergies was identified (OR: 1.28, 95% CI: 1.11, 1.46). Three studies 
85 examined a HDP (including preeclampsia) and allergic rhinitis relationship, with effect estimates 
86 ranging from 1.14 to 2.10. Studies were classified as low or low-moderate risk of bias, while 
87 GRADE certainty of findings were low to very low.
88 Conclusions: While preeclampsia was associated with a possible increased risk of asthma in 
89 offspring, there was no evidence for a relationship between other HDP and asthma. There is a lack 
90 of published literature examining the association between HDP and eczema, food allergy and 
91 allergic rhinitis. Further primary research is warranted to gain a better understanding of the 
92 association between HDP and the risk of childhood atopic disease. 
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94 Introduction
95 Hypertensive disorders of pregnancy (HDP) are estimated to affect up to 10% of all pregnancies, 
96 and are a recognised risk factor for maternal and prenatal morbidity and mortality(1-3). The 
97 International Society for the Study of Hypertension in Pregnancy (ISSHP) categorises HDP as: 
98 “chronic hypertension”, “white-coat hypertension”, “masked hypertension”, “gestational 
99 hypertension”, and “preeclampsia” (de novo/superimposed on chronic hypertension(4). 
100 Hypertensive disorders of pregnancy are associated with maternal inflammation, oxidative stress 
101 and disruption of blood flow to the placenta, all of which can impact fetal development(5).
102 It is well established that pregnancy and early childhood are critical time periods for the 
103 development of airways and the immune system, and genetic and environmental factors play 
104 important roles in determining the development of atopic disorders in offspring(6-8). Childhood 
105 atopic disorders include asthma, eczema (also known as atopic dermatitis), food allergies and 
106 allergic rhinitis, and are characterised by the development of an allergen-specific T helper type 2 
107 (Th2) response which often (but not always) includes the development of specific immunoglobulin 
108 (IgE) targeted against the allergen(9). The presence of these specific antibodies is detected using a 
109 skin prick test or a blood test(8). 
110 Previous epidemiological research has indicated an association between HDP and atopic disorders 
111 in offspring(10, 11). For example, a population-based registry cohort with data on over 1.5 million 
112 people suggested an association between preeclampsia and asthma after controlling for several 
113 potential confounders(10)  However, results are conflicting as some relatively smaller studies do not 
114 suggest an association(12, 13). Furthermore, all studies on this topic were original studies, with no 
115 systematic review conducted, to date.
116 Given that HDP are among the most common adverse prenatal conditions(3), and the lack of 
117 general consensus on this topic, collating existing evidence examining a HDP-atopic disorder 
118 association is timely. Therefore, the aim of this study was to synthesise the available published 
119 literature on the relationship between HDP and atopic disorders in the offspring in the form of a 
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121 Methods
122 The systematic review was based on the following requirements:
123 Population: Pregnant women and their children
124 Intervention/Exposure: HDP (primary exposure: preeclampsia; secondary exposures: other 
125 HDP)
126 Comparison: No preeclampsia/no HDP
127 Outcomes: Atopic disorders (outcome 1: asthma; outcome 2: eczema; outcome 3: food allergies; 
128 outcome 4: allergic rhinitis)
129
130 Data Sources and Search Strategy
131 Based on a pre-prepared protocol (Appendix 1), and in accordance with the Preferred Reporting 
132 Items for Systematic Reviews and Meta Analyses (PRISMA) guidelines(14), two reviewers (NC 
133 and GMM) conducted a systematic literature search of four electronic databases: PubMed, 
134 Embase, Web of Science and CINAHL, from inception through to April 21, 2020. 
135 Search terms associated with HDP and asthma, eczema, food allergy and allergic rhinitis were 
136 combined according to the principles of Boolean Logic (AND/OR/NOT) and using Medical 
137 Subject Headings (MeSH). For example, (“Pre-eclampsia” OR “hypertensive disorders of 
138 pregnancy”) AND (“asthma” OR “eczema” OR “food allergy” OR “allergic rhinitis”). The full 
139 search strategy is included in Appendix 2. Results were limited to human studies, published in the 
140 English language. No restrictions were placed on publication date, location of study or age of 
141 participants. Searches of the electronic databases were supplemented by hand-searching the 
142 reference lists of included studies for further potentially eligible studies, and contact with authors 
143 was made when a conference proceeding only was located to identify if the relevant full-text paper 
144 had been published. A post-hoc search of PubMed was also conducted adding the keywords 




149 Titles and abstracts of studies retrieved from each database search were stored and managed in 
150 Endnote reference manager©. Two review authors (NC, GMM) independently reviewed the titles 
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152 consensus on eligibility could not be achieved, a third review author (ASK) was involved in the 
153 discussion. Eligibility criteria for inclusion in the systematic review included:
154  English language cohort, case-control or cross-sectional published studies where a HDP 
155 diagnosis was reported, and the outcome of interest was a childhood atopic disorder 
156 (asthma, eczema, food allergy and/or allergic rhinitis). 
157  Where the outcome of interest was asthma, this must be clearly defined (i.e. not wheezing). 
158  Peer-reviewed, epidemiological studies containing original data only.
159  Examining the association between HDP and atopic disease in the offspring was part of the 
160 main objective of the study.
161  Diagnosis of HDP could be confirmed through self-reporting (following doctor diagnosis) 
162 and/or medical records.
163  Diagnosis of asthma, eczema, food allergies and allergic rhinitis could be confirmed 
164 through maternal-reporting/self-reporting (following doctor diagnosis) and/or medical 
165 records and/or clinical diagnosis and/or skin prick/blood test.
166  Among studies conducted on the same population with overlapping time-periods, we chose 
167 the study covering the longest time-period for inclusion in the meta-analysis to avoid using 
168 the same population more than once. 
169  Conference abstracts were excluded. 
170
171 Data Extraction
172 Two reviewers (NC, SAK) independently extracted data from all studies deemed eligible for 
173 inclusion, using a standardized data collection form. The extracted data included: the first author, 
174 publication year, data source, study design, region, study period, sample size, how both exposure 
175 and outcome were diagnosed, any confounders adjusted for (if any), matching factors (if any) and 
176 the overall result. Any discrepancies were resolved by consensus with a third reviewer (GMM). 
177 Authors of six studies were contacted to provide crude estimates and 95% confidence intervals (or 
178 raw data to allow us to compute effect estimates). A reply was received from four authors, of 
179 which, three could provide us with the additional information. 
180
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182 A funnel plot was used to visually assess the presence of publication bias for preeclampsia-asthma 
183 studies only. Quality assessment of included studies was carried out by two reviewers (NC, SAK) 
184 independently using an appropriate quality assessment tool described by McDonald et al.(15), while 
185 any discrepancies were resolved by a third reviewer (GMM) if necessary. The bias classification 
186 tool assesses the six most common types of bias associated with observational studies. For each 
187 eligible study, selection bias, exposure bias, outcome bias, confounding bias, analytic bias and 
188 attrition bias were rated as minimal, low, moderate or high. An overall likelihood of bias based on 
189 the total of the six types of bias was then reported. For example, risk of attrition bias was deemed 
190 minimal if there was “none or <10% attrition, and reasons for loss of follow up [were] explained”, 
191 while conversely risk of attrition bias was deemed as high if there was “>20% attrition, and 
192 reasons for loss of follow up [was] not explained”. The Grading of Recommendations Assessment, 
193 Development, and Evaluation (GRADE) approach was used to rate the certainty of findings. In the 
194 GRADE approach, observational studies start as low-quality evidence. Five factors (risk of bias, 
195 imprecision, inconsistency, indirectness, and publication bias) may lead to rating down the quality 
196 of evidence and three factors (large effect, dose response, and if residual confounding is likely to 
197 decrease rather than increase the magnitude of effect) may lead to rating up(16). 
198
199 Statistical Analysis
200 Where data permitted, Review Manager 5.3 was used to conduct meta-analyses. Using the generic 
201 inverse variance method, the overall pooled estimate between preeclampsia and asthma was 
202 calculated. The studies that adjusted for potential confounders during the analysis stage were 
203 referred to as adjusted estimates. Crude estimates and adjusted estimates were analysed separately. 
204 The overall pooled estimate between other HDP and asthma was also calculated using the generic 
205 inverse variance method (with both crude and adjusted estimates analysed separately). Similarly, 
206 the overall pooled estimate between preeclampsia and eczema was also calculated using the same 
207 method (adjusted estimates only due to lack of data).  
208 A random-effects model was used to calculate pooled odds ratios with 95% confidence intervals. 
209 The random-effects model was selected to allow for differences in the ‘exposure effect’ from 
210 study to study(17). Forest plots were used to present the results. Heterogeneity was measured using 
211 the I2, and was categorized as: 0-40% - might not be important; 30-60% - may represent moderate 
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213 considerable heterogeneity, according to the Cochrane Handbook criteria(18). Where data did not 
214 allow for meta-analyses to be conducted, a narrative synthesis was conducted to present results.
215 Subgroup/sensitivity analysis: Subgroup/sensitivity analyses according to study design and 
216 location were decided a priori.
217 Post hoc sensitivity analyses: Among asthma studies, three population-based registry studies with 
218 overlapping time-periods were conducted in Denmark(10, 19, 20), while this occurred among two 
219 eczema studies(10, 20). Therefore, while the main analyses included Stokholm et al(10) (as this study 
220 covered the longest time-period), we also conducted a sensitivity analysis including one Danish 
221 cohort study at a time. In order to determine if a wide range of follow-up (i.e from early childhood 
222 to >18 years) had an impact on findings, we conducted post-hoc sensitivity analyses excluding 
223 (adjusted) studies with follow-up over 18 years of age(21).
224 To explore clinical/methodological sources of heterogeneity among preeclampsia-asthma studies, 
225 we excluded the large registry based cohort studies, therefore examining a preeclampsia-asthma 

















243 The initial search produced 2,833 results prior to the removal of duplicates. Once duplicates were 
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245 articles were reviewed. Twenty-six articles were excluded for reasons outlined in Figure 1, 
246 resulting in the identification of 11 eligible studies. Following review of the reference lists of each 
247 eligible study, three further eligible studies were identified. Therefore, a total of 14 unique studies 
248 were included in the systematic review; 13 of which included data on asthma, five on eczema, one 
249 on food allergies, and three on allergic rhinitis.
250
251 Characteristics of Eligible Studies
252 Of the 13 studies that included data on asthma, there were 12 cohort studies(7, 10-13, 20-26) and one 
253 case-control study(19). Range of follow-up was between age <1 year and 13 years for the majority 
254 of studies(7, 10, 12, 13, 22-26), while four studies followed participants up to adulthood (up to 27 
255 years)(11, 19-21). The average sample size among asthma studies was 537,198, with a minimum of 
256 806(23) and a maximum of 1,698,638 participants(10). 
257 Of the five studies that include data on eczema, four were cohort studies(10, 20, 22, 26) and one was 
258 cross-sectional with a retrospective cohort analysis(27). Range of follow-up was between age 3 
259 years and 14 years for four studies(10, 22, 26, 27), while one study followed participants up to 27 
260 years(20). The average sample size was 654,718, with a minimum of 1,025(22) and a maximum of 
261 1,698,638(10).
262 One cohort study examined food allergies (n=1,698,638) up to seven years of age(10), and three 
263 cohort studies examined allergic rhinitis (age ranges 3-14 years)(10, 21, 22) with an average sample 
264 size of 1,702,986, a minimum of 1,025(22) and a maximum of 1,698,638(10).
265 Ascertainment of HDP was determined using medical records in 11 studies(7, 10-12, 19, 20, 22-26), 
266 measured directly in one study(13) and was self-reported in two studies(21, 27). Asthma diagnosis was 
267 determined using medical records in eight studies(7, 10-12, 19, 20, 24, 26), while parental reporting was 
268 used in five studies(13, 21-23, 25). A diagnosis of eczema was determined using medical records in 
269 three studies(10, 20, 26), and parental reporting in two studies(22, 27). Food allergy data was obtained 
270 from the Danish National Patient Register(10), while data on allergic rhinitis was parental reported 
271 in two studies(21, 22), and obtained from the Danish National Patient Register in one study(10).
272 The confounders that were adjusted for included, amongst others: offspring gender, mode of 
273 delivery, gestational age, birthweight, parity, maternal age, smoking during pregnancy, maternal 
274 body mass index, maternal asthma, maternal education and allergen exposure. A summary of the 
275 eligible studies (including a full list of confounding factors) examining the association between 
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277
278 Meta-Analysis Results
279 Asthma: Thirteen studies investigating the association between HDP and asthma were identified(7, 
280 10-13, 19-26). Of these, 11 studies reported crude estimates(7, 10-12, 19, 21-26), and 11 studies reported 
281 adjusted estimates(7, 10, 12, 13, 19-25). Effect estimates ranged from 1.03-1.89 among the 11 studies 
282 reporting crude estimates, and from 0.80-1.34 among the 11 studies reporting adjusted estimates. 
283 Eight studies (conducted on different populations without overlapping time-periods) included 
284 crude estimates for a preeclampsia-asthma relationship(7, 10, 11, 22-26), while seven studies included 
285 adjusted estimates on preeclampsia-asthma(7, 10, 13, 22-25). Crude pooled estimates (including 
286 3,919,377 participants) for preeclampsia resulted in an odds ratio (OR) of 1.22 (95% CI: 1.12, 
287 1.33) (I2=69%) (Figure 2). Adjusted estimates (including 3,645,773 participants) reduced the 
288 preeclampsia-asthma OR to 1.14 (95% CI: 1.04, 1.26) (I2=62%) (Figure 3). 
289 Three studies included crudes estimates for other HPD-asthma(12, 21, 25), while four studies included 
290 adjusted estimates(12, 13, 21, 25). The crude pooled result (including 250,104 participants) for other 
291 HDP-asthma was 1.09 (95% CI: 1.02, 1.16) (I2=0%) (Figure 4), while the adjusted pooled result 
292 (including 254,998 participants) was 1.02 (0.96, 1.09) (I2=0%) (Figure 5).
293 Eczema: Five studies were identified that investigated the association between all HDP and 
294 eczema (atopic dermatitis) with effect estimates ranging from 0.96-1.14 among studies providing 
295 crude estimates, and from 0.90-1.84 among studies providing adjusted estimates(10, 20, 22, 26, 27). 
296 Two studies (conducted on different populations without overlapping time-periods) provided 
297 adjusted estimates (including 1,699,663 participants) for the association between preeclampsia and 
298 eczema(10, 22) resulting in a pooled OR of 1.06 (95% CI: 0.98, 1.14) (I2=0%) (Figure 6). One 
299 Danish based study(20) (n=1,545,443) could not be included in the meta-analysis as it was 
300 conducted on a similar population with overlapping time-periods to Stokholm et al(10): 1.04, (95% 
301 CI: 0.79, 1.38). One study provided a crude estimate only (n=24,690) for the relationship between 
302 eclampsia and eczema: 0.96, (95% CI: 0.73, 1.27)(26). Finally, one study provided an adjusted 
303 estimate only (n=3,794) for the relationship between other HDP and eczema: 1.08, (95% CI: 0.71, 
304 1.64)(27).
305 Subgroup/sensitivity analysis:
306 Study design: All seven cohort studies included in the meta-analysis(7, 10, 13, 22-25) (with adjusted 
307 estimates) examining a preeclampsia-asthma association were cohort studies. All four studies 
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309 both studies (with adjusted estimates) examining a preeclampsia-eczema relationship were cohort 
310 studies(10, 22). 
311 Location: Six adjusted preeclampsia-asthma studies were conducted in Europe(7, 10, 13, 22, 24, 25) 
312 (pooled OR: 1.14, 95% CI: 1.03, 1.26), while one adjusted preeclampsia study was conducted in 
313 the United States(23) (OR: 1.21, 95% CI: 0.51, 2.87). Three adjusted studies examining other HDP-
314 asthma were conducted in Europe(13, 21, 25) (pooled OR: 1.04, 95% CI: 0.88, 1.23), while one study 
315 was conducted in Australia(12) (OR: 1.02, 95% CI: 0.95, 1.10). Both studies (with adjusted 
316 estimates) examining a preeclampsia-eczema relationship were conducted in Europe(10, 22) (Table 
317 1). 
318 Post hoc sensitivity analysis: Including one Danish cohort study with overlapping time-periods at 
319 a time did not materially change results. Adjusted OR for preeclampsia-asthma including 
320 Stokholm et al(10): 1.14 (95% CI: 1.04, 1.26 - I2=62%), including Wu et al(20): 1.15 (95% CI: 1.03, 
321 1.29 - I2=38%), and including Liu et al(19): 1.19 (95% CI: 1.12, 1.26 - I2=31%). Adjusted OR for 
322 preeclampsia-eczema including Stokholm et al(10): 1.06 (95% CI: 0.98, 1.14 - I2=0%), and 
323 including Wu et al(20): 1.01 (95% CI: 0.80, 1.27 - I2=0%).
324 Excluding the other HDP-asthma study with follow-up over 18 years of age did not materially 
325 change results(21): (other HDP-asthma: OR 1.02, 95% CI: 0.96, 1.09 - (I2=0%)). All other studies 
326 included in the meta-analyses were followed-up for <18 years (preeclampsia-asthma: OR 1.14, 
327 95% CI: 1.04, 1.26 - (I2=62%)), (preeclampsia-eczema: OR 1.06, 95% CI: 0.98, 1.14 - (I2=0%)) 
328 (see Table 1 for a summary of results).
329 Excluding the large registry based cohort studies among preeclampsia-asthma studies(7, 10, 24) (and 
330 therefore examining a preeclampsia-asthma relationship among studies that used parent-reported 
331 measures to determine a diagnosis of asthma(13, 22, 23, 25)) resulted in an OR of 1.08 (95% CI: 0.78, 




336 Narrative Synthesis Results
337 Food allergies and allergic rhinitis: As the systematic search identified only one study exploring 
338 the association between HDP and food allergies(10) and three studies exploring the association 
339 between HDP and allergic rhinitis(10, 21, 22), meta-analyses were not conducted for these outcomes. 
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341 preeclampsia and food allergies in offspring: adjusted estimate 1.21 (95% CI: 1.05, 1.39). This 
342 same study(10) also examined allergic rhinitis and reported a positive association between 
343 preeclampsia and allergic rhinitis: adjusted estimate 1.14 (95% CI, 1.05, 1.24). A second study 
344 which examined preeclampsia-allergic rhinitis (stratified by mild/moderate and severe 
345 preeclampsia)(22) reported an adjusted OR of 1.21 (95% CI: 0.70, 2.07) for mild/moderate 
346 preeclampsia and 2.10 (95% CI: 0.86, 5.11) for severe preeclampsia. Finally, one study examined 
347 other HDP-allergic rhinitis(21), resulting in an adjusted OR of 1.42 (95% CI: 0.84, 2.40). A 
348 summary of these studies can be found in Appendices 5 and 6.
349
350 Bias and Heterogeneity
351 Visual assessment of the funnel plot did not indicate presence of publication bias (Appendix 8, 
352 eFigure 2). There was substantial heterogeneity among preeclampsia-asthma studies (I2=62%) and 
353 low heterogeneity among studies that include other HDP and asthma (I2=0%) based on adjusted 
354 estimates. Similarly, there was low heterogeneity among preeclampsia-eczema studies (I2=0%). 
355 Heterogeneity between preeclampsia-asthma studies was possibly due to the larger registry based 
356 cohort studies as heterogeneity was reduced to 0% these were excluded(7, 10, 24) (Appendix 7, 
357 eFigure 1). In addition to this, it is possible that varying methods of exposure and outcomes 
358 measures (as outlined in Appendix 3) may have resulted in clinical/methodological sources of 
359 heterogeneity. For example, the I2 among preeclampsia-asthma studies that use parent-reported 
360 measures(13, 22, 23, 25) to determine a diagnosis of asthma was 0% (Appendix 7, eFigure 1). The 
361 majority of studies were classified as ‘low’ or ‘low-moderate’ risk of bias (Appendices 9-12). 

































386 The objective of this systematic review and meta-analysis was to investigate the association 
387 between HDP and asthma, eczema, food allergy and allergic rhinitis in offspring, yielding three 
388 principal findings.
389 First, the adjusted pooled estimate suggested that preeclampsia was associated with a 14% 
390 increase in the likelihood of asthma compared to those unexposed to preeclampsia (OR: 1.14, 95% 
391 CI: (1.04, 1.26), while the adjusted pooled estimate examining the other HDP-asthma relationship 
392 produced an OR of 1.02 (95% CI: 0.96, 1.09). It was proposed by Stokholm et al(10) that the in 
393 utero exposure to excessive inflammation associated with preeclampsia could be leading to the 
394 preeclampsia-asthma association, proposing that the skewed distribution of T cells in preeclamptic 
395 women could increase IgE levels in offspring, thus increasing the risk of asthma(10). This may 
396 partly explain why an association was observed between preeclampsia-asthma, and not other 
397 HDP-asthma. Furthermore, fetal growth restriction, which is now included in the definition of 
398 preeclampsia, as per ISSHP guidelines(4), may also play a role and has been linked to an increased 
399 risk of asthma in previous literature(28).  
400 Second, the adjusted pooled estimate examining a preeclampsia-eczema relationship produced an 
401 OR of 1.06 (95% CI: 0.98, 1.14). However, only two studies (conducted on different populations 
402 without overlapping time-periods) were identified for inclusion in the meta-analysis(10, 20, 22), 
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404 Third, there was a dearth of literature supporting an association between HDP and food allergies 
405 and HDP and allergic rhinitis. Only one publication was identified exploring the relationship 
406 between preeclampsia and food allergy(10). This study reported an OR of 1.21 (95% CI: 1.05, 1.39) 
407 and proposed that the risk of food allergy increased as the duration of exposure to preeclampsia 
408 was extended(10). Given the increasing prevalence of childhood onset food allergies(29), it is timely 
409 that further research in this area is initiated. Finally, only three studies were identified exploring 
410 the association between HDP and allergic rhinitis(10, 21, 22). All three studies reported a positive 
411 association between HDP and allergic rhinitis (with effect estimates ranging from 1.14 to 2.10, 
412 and results of two of these studies spanning the null value(21, 22)) citing the involvement of an 
413 inflammatory response involving a skewed distribution of T cells in the preeclamptic women as 
414 the potential biological mechanism(10, 22). However, further research is warranted to further 
415 investigate if such an association exists, and if so, what biological mechanisms are involved. 
416
417 Strengths and Limitations
418 This systematic review contains several strengths. A thorough search of four relevant electronic 
419 databases was conducted, supplemented by manually reviewing the reference lists of the eligible 
420 studies for further suitable studies. Each process of the systematic review was carried out by two 
421 independent reviewers and PRISMA guidelines were followed throughout(14). Finally, we 
422 attempted to contact several authors for further information to ensure data contained within the 
423 meta-analysis was as comprehensive as possible. 
424 However, this systematic review also contains several limitations. We included English-language 
425 studies only, potentially overlooking relevant, non-English language studies. We only included 
426 published, full-text articles, therefore excluding data from grey literature or conference 
427 proceedings. Furthermore, as the full search strategy may have been lacking in keywords such as 
428 “bronchial spasm” OR “bronchial hyperreactivity” OR “respiratory hypersensitivity”, we 
429 conducted a post-hoc search of PubMed, adding these words to the search strategy. While this 
430 increased the number of hits retrieved, no new relevant studies were identified in the process. The 
431 small number of published studies also limited this review. While visual assessment of the funnel 
432 plot of preeclampsia-asthma studies did not indicate the presence of publication bias, it was not 
433 feasible to generate a funnel plot for other HDP-asthma or preeclampsia-eczema due to the limited 
434 number of published studies. In addition, it is important to note that the reported positive 
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436 seven studies were included in the meta-analysis, and a high degree of heterogeneity was reported 
437 (I2 =62%).
438 Studies included in this systematic review also contain some limitations. For example, while the 
439 majority of studies were classified as ‘low’ or ‘low-moderate’ risk of bias, GRADE certainty of 
440 findings were low to very low, indicating that the true effect may be different from the estimated 
441 effect(16). Furthermore, while the majority of studies attempted to control for confounding in their 
442 analysis phase, residual or unmeasured confounding cannot be ruled out in observational 
443 studies(30). Selection of potential confounders varied in each study and were identified from 
444 existing literature or the research team’s knowledge of the subject, however only one study 
445 appears to have aided the selection of confounders using a directed acyclic graph(25). It is 
446 important to acknowledge that some of the factors controlled for, as potential confounders, could 
447 in fact be potential mediators of the HDP-atopic disorder association. For example, eight studies 
448 controlled for a combination of mode of delivery, gestational age and birthweight, which may 
449 have biased results towards the null and thus, should be interpreted with caution(10-12, 20-23, 25, 31). 
450 All studies with adjusted estimates considered maternal age and infant sex as potential 
451 confounders. Seven of the 13 eligible asthma studies recognised the potential confounding role of 
452 maternal asthma(7, 10, 19, 21, 22, 24, 25), while maternal smoking was also identified as a potential 
453 confounder in seven studies(7, 10, 13, 19, 21, 22, 25), with the majority of these studies attenuating 
454 towards the null when adjusted(7, 10, 13, 19, 21, 22). However, exposure to certain environmental factors 
455 during pregnancy, which may be associated with asthma development could also be considered as 
456 potential confounders. Such factors include exposure to traffic pollution, antibiotic use and viral 
457 infection(32). The former was not considered in any of the included studies, while antibiotic use 
458 was adjusted for in two studies(10, 21), and viral infection was considered as a confounder in only 
459 one study(24). 
460 Additionally, few studies included data on severity of preeclampsia or other HDP(11, 20, 22), and 
461 were limited by small sample sizes (as fewer than ten cases of asthma were exposed to severe 
462 preeclampsia in one study)(22), and residual confounding (as confounders were not adjusted for 
463 when examining preeclampsia-asthma specifically in a separate study)(11). Finally, the role of 
464 antihypertensive medication used during pregnancy should be explored in order to determine its 
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468 This systematic review and meta-analysis indicates that preeclampsia may be associated with an 
469 increased risk of asthma in the offspring, while there was no evidence for a relationship between 
470 other HDP and asthma. Further research is warranted to validate these findings and to determine if 
471 the observed relationship is causal. Insufficient published literature was available to substantiate 
472 whether an association exists between HDP and eczema, food allergy and/or allergic rhinitis. 
473 Further primary research is needed to explore these associations.
474
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Forest Plots for Studies of the Association between Preeclampsia and Asthma
Figure 2 Forest Plot for the Association of Preeclampsia with Asthma (crude estimates).
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Forest Plots for Studies of the Association between other Hypertensive Disorders of 
Pregnancy (HDP) and Asthma
Figure 4 Forest Plot for the Association of other HDP with Asthma (crude estimates).
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Forest Plot for Studies of the Association between Preeclampsia and Eczema










This article is protected by copyright. All rights reserved
Table 1: Meta-analyses for HDP-Asthma and HDP-Eczema
Asthma Number of studies N OR 95% CI I2
Preeclampsia (crude) 8 3919377 1.22 (1.12, 1.33) 69%
Preeclampsia (adjusted) 7 3645773 1.14 (1.04, 1.26) 62%
Other HDP (crude) 3 250104 1.09 (1.02, 1.16) 0%
Other HDP (adjusted) 4 254998 1.02 (0.96, 1.09) 0%
Study designa
Cohort (preeclampsia) 7 3645773 1.14 (1.04, 1.26) 62%
Cohort (other HDP) 4 254998 1.02 (0.96, 1.09) 0%
Locationa 
Europe (preeclampsia) 6 3644967 1.14 (1.03, 1.26) 68%
United States (preeclampsia) 1 806 1.21 (0.51, 2.87) NA
Europe (other HDP) 3 14487 1.04 (0.88, 1.23) 0%
Australia (other HDP) 1 240511 1.02 (0.95, 1.10) NA
Including one Danish cohort study at a timea
Preeclampsia 7 3645773 1.14 (1.04, 1.26) 62%
Preeclampsia 7 3492578 1.15 (1.03, 1.29) 38%
Preeclampsia 7 3217867 1.19 (1.12, 1.26) 31%
Excluding studies with >18 years of follow-upa
Preeclampsia 7 3645773 1.14 (1.04, 1.26) 62%
Other HDP 3 252379 1.02 (0.96, 1.09) 0%
Excluding the large registry based cohort studiesa
Preeclampsia 4 13699 1.08 (0.78, 1.48) 0%
Eczema Number of studies N OR 95% CI I2
Preeclampsia (adjusted) 2 1699663 1.06 (0.98, 1.14) 0%
Study designa
Cohort (preeclampsia) 2 1699663 1.06 (0.98, 1.14) 0%
Locationa
Europe (preeclampsia) 2 1699663 1.06 (0.98, 1.14) 0%
Including one Danish cohort study at a timea
Preeclampsia 2 1699663 1.06 (0.98, 1.14) 0%
Preeclampsia 2 1546468 1.01 (0.80, 1.27) 0%
Excluding studies with >18 years of follow-upa
Preeclampsia 2 1699663 1.06 (0.98, 1.14) 0% 
aIncludes all studies that adjusted for confounders in the analysis phase.
A
cc
ep
te
d 
A
rt
ic
le
